[Sofosbuvir/velpatasvir/voxilaprevir (chronic hepatitis C) - Addendum to Commission A17-35]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003362
German
Original Title:
Sofosbuvir/Velpatasvir/Voxilaprevir (Chronische Hepatitis C) - Addendum zum Auftrag A17-35
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a18-05.html
Year Published:
2018
URL for published report:
https://www.iqwig.de/download/A18-05_Sofosbuvir-Velpatasvir-Voxilaprevir_Addendum-zum-Auftrag-A17-35_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Hepatitis C, Chronic
- Sofosbuvir
- Antiviral Agents
- Drug Therapy, Combination
Keywords
- Sofosbuvir
- Velpatasvir
- Voxilaprevir
- Hepatitis C ? Chronic
- Benefit Assessment
- NCT02607800
- NCT02639338
- NCT02639247
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.